针对PACAP:超越偏头痛到集群,月经和创伤后头痛
Lanfranco Pellesi1, Mona Ameri Chalmer2,3, Song Guo2,3
1Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Campusvej 55, 5230, Odense, Denmark. lpellesi@health.sdu.dk.
Advances in therapy
|March 18, 2025
概括
pituitary adenylate cyclase-activating peptide (PACAP) 途径是头痛疾病的关键,影响疼痛和神经血管系统. 准PACAP显示出治疗偏头痛和其他头痛的前景.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 疼痛研究 疼痛研究
背景情况:
- pituitary adenylate cyclase-activating peptide (PACAP) 途径越来越多地被认为是它在头痛病理生理学中的作用.
- PACAP与特定的受体 (PAC1,VPAC1,VPAC2) 相互作用,并影响神经血管和激素调节.
- 有证据表明,PACAP与三和副交感系统的调制有关,这与集群头痛和月经性偏头痛有关.
研究的目的:
- 综合当前关于PACAP在头痛疾病中的作用的证据.
- 为了确定理解PACAP在头痛病理生理学中的精确机制的差距.
- 探索针对PACAP途径用于头痛管理的治疗潜力.
主要方法:
- 这项研究是对现有科学文献的叙事性审查.
- 该审查综合了临床前和临床研究的证据.
- 专注于PACAP在各种类型的头痛中的参与及其治疗影响.
主要成果:
- PACAP在调节疼痛通路方面发挥着重要作用,包括那些涉及创伤后头痛的人.
- 针对PACAP信号的早期临床试验已经显示出有希望的结果,特别是在偏头痛预防中.
- PACAP途径与集群头痛和月经性偏头痛的病理生理学有关.
结论:
- PACAP途径是一系列头痛疾病的潜在治疗点.
- 需要进一步的研究,以充分阐明PACAP在不同类型的头痛中的机制.
- 成功的临床试验可能会为数以百万计的头痛患者带来新的治疗方法.
相关概念视频
01:25Analgesia and Pain Management
415
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
415
01:27Panic Disorder
23
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
23
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
145
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
145